Private Healthcare Summit 2026 – Stream B

- What does good medically assisted weight loss look like

- Is there a lack of regulation for the use of GLP-1 Inhibitors

- How will GLP-1 Inhibitors ingrate with the wider healthcare ecosystem in the long run

The emergence of GLP-1 inhibitors has transformed the treatment landscape for obesity and metabolic health, driving unprecedented demand across both clinical and consumer settings. But how can healthcare systems respond sustainably while ensuring safe, equitable, and effective use?

- How will interoperability of Technology improve sector integration

- The need to streamline patient data and records and how this will improve the patient experience

- Data protection, governance and regulation

As demand pressures grow, collaboration between the NHS and private sector is becoming increasingly important in delivering timely and effective care. However, true integration depends on more than policy—it requires robust technological interoperability. How can systems be designed to enable seamless collaboration across organisational boundaries?